A trial of the tolerability and pharmacodynamics of an intranasal formulation of midazolam in healthy volunteers.

Trial Profile

A trial of the tolerability and pharmacodynamics of an intranasal formulation of midazolam in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2015

At a glance

  • Drugs Midazolam (Primary) ; Midazolam (Primary)
  • Indications Epilepsy; Seizures
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 24 Nov 2015 Results will be presented at the 69th Annual Meeting of the American Epilepsy Society (AES), according to an Upsher-Smith media release.
    • 02 Sep 2015 Results published in the Epilepsia.
    • 23 Jun 2013 Results presented at the 30th International Epilepsy Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top